(NewsDirect)
Willow Bioscience CEO Dr Chris Savilejoined Steve Darling from Proactive to share news the company hasagreed to a Master Services Agreement with an innovative biotechcompany with the focus on age-related diseases. This partnership willsee the company develop precision fermentation processes for a classof molecules to develop novel solutions for age-related diseases.
Savile also told Proactive about another key partnership withKalsec Inc to develop an enzyme used in production of a new, advancedingredient used in natural beverage applications. This is the secondcollaborative development program the two parties will be working on.The goal is to commercialize these products quickly and effectively,leveraging partnerships for market access while retaining the optionto bring proprietary ingredients to market independently.
Contact Details
Proactive Investors
+1604-688-8158
na-editorial@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.